<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats
2
Pharmacokinetics and Molecular Docking Studies of Uridine Derivatives as SARSCOV-2 Mpro Inhibitors
3
Pharmacokinetics and Pharmacodynamic Effects of Flunixin after Intravenous, Intramuscular and Oral Administration to Dairy Goats
4
Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses
5
Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses
6
Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
7
Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors
8
Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy
9
Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements
10
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites
11
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy
12
Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy
13
Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy
14
Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids
15
Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-image-tyrosine as oncologic PET tracer
16
Pharmacokinetics and residual behaviour in milk of oxytetracycline in cows following administration of uterine pessaries
17
Pharmacokinetics and residues of a new oral amoxicillin formulation in piglets: A preliminary study
18
Pharmacokinetics and residues of tetracycline in crucian carp muscle using capillary electrophoresis on-line coupled with electrochemiluminescence detection
19
Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass
20
Pharmacokinetics and tissue and milk disposition of Tilmicosin in sheep after single administrations
21
Pharmacokinetics and tissue distribution of a novel marine fibrinolytic compound in Wistar rat following intravenous administrations
22
Pharmacokinetics and Tissue Distribution of Antimony(v) after Multiple Intramuscular Administrations in the Hamster
23
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy
24
Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography–mass spectrometry: Evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier
25
Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice
26
Pharmacokinetics and Tolerability of Iopromide 240 After Lumbar Myelography
27
Pharmacokinetics in gene delivery
28
Pharmacokinetics in pregnancy
29
Pharmacokinetics in the elderly
30
Pharmacokinetics in the newborn
31
Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses
32
Pharmacokinetics of a Mono-pyridinium-mono-aldoxime (K-347), a Potential Antidote in Organophosphate Poisoning
33
Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat
34
Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats
35
Pharmacokinetics of alprazolam in elderly patients with multiple diseases
36
Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design
37
Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension Formulations in Human Volunteers
38
Pharmacokinetics of an ampicillin–sulbactam combination after intravenous and intramuscular administration to neonatal calves
39
Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors
40
Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration
41
Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs
42
PHARMACOKINETICS OF CALCIUM FROM CALCIUM SUPPLEMENTS IN HEALTHY VOLUNTEERS
43
Pharmacokinetics of calycopterin and xanthmicrol, two polymethoxylated hydroxyflavones with anti-angiogenic activities from Dracocephalum kotschyi Bioss
44
Pharmacokinetics of Cefepime Following Intravenous and Intramuscular Administration in Sheep
45
Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats
46
Pharmacokinetics of ceftazidime in buffalo calves following intravenous and intramuscular administration
47
Pharmacokinetics of ceftiofur sodium in equine pregnancy
48
Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration
49
Pharmacokinetics of Cephalexin in the Horse After Intravenous and Intramuscular Administration of Two Formulations
50
Pharmacokinetics of ciprofloxacin in bath medicated hybrid tilapias using enzyme linked immunosorbent assay (ELISA)
51
PHARMACOKINETICS OF CIPROFLOXACIN IN NORMAL RABBITS AND CHANGES OBSERVED IN INDUCED DEHYDRATED STATE
52
Pharmacokinetics of ciprofloxacin in sheep following intravenous and subcutaneous administration
53
Pharmacokinetics of ciprofloxacin in the rat and its interaction with cyclosporin A: a microdialysis study Original Research Article
54
Pharmacokinetics of Clozapine: An Investigate the Potential Molecular Mechanisms of Action
55
Pharmacokinetics of combined doxorubicin and paclitaxel in mice
56
Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin
57
Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats
58
Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in broiler chickens
59
Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in pigs
60
Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects
61
Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis
62
Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration
63
Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration
64
Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis
65
Pharmacokinetics of Doramectin and Ivermectin After Oral Administration in Horses*
66
Pharmacokinetics of doramectin in lactating dairy sheep and suckling lambs Original Research Article
67
Pharmacokinetics of doxycycline in sheep after intravenous and oral administration
68
Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits
69
Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin and Its Interaction With Diclofenac After Intravenous Administration in Buffalo Calves
70
Pharmacokinetics of Enrofloxacin and its Metabolite Ciprofloxacin in Goats given Enrofloxacin Alone and in Combination with Probenecid
71
Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves
72
Pharmacokinetics of ergosterol in rats using rapid resolution liquid chromatography–atmospheric pressure chemical ionization multi-stage tandem mass spectrometry and rapid resolution liquid chromatography/tandem mass spectrometry
73
Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats
74
Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization
75
Pharmacokinetics of fexofenadine in healthy Taiwanese volunteers
76
Pharmacokinetics of fleroxacin in horses
77
Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma
78
Pharmacokinetics of gadoversetamide injection, a gadolinium-based contrast agent, in pediatric patients
79
Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography–tandem mass spectrometry
80
Pharmacokinetics of Gefodizime in Patients with Various Degrees of Renal Failure
81
Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation
82
Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs
83
Pharmacokinetics of HZ08 in rats by liquid chromatography–tandem mass spectrometry
84
Pharmacokinetics of ingested fluoride: Lack of effect of chemical compound
85
Pharmacokinetics of Intravascularly Administered 65Zinc in Channel Catfish (Ictalurus punctatus)
86
Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles
87
Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia
88
Pharmacokinetics of kadsurenone and its interaction with cyclosporin A in rats using a combined HPLC and microdialysis system
89
Pharmacokinetics of kakkalide and its main metabolites in rat plasma determined by HPLC-DAD and LC–MSn
90
Pharmacokinetics of ketoprofen enantiomers after intravenous administration of racemate in camels: effect of gender
91
Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
92
Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression
93
Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging
94
Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches
95
Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats
96
Pharmacokinetics of melamine in pigs following intravenous administration
97
Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs
98
Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration
99
Pharmacokinetics of metronidazole in rat blood, brain and bile studied by microdialysis coupled to microbore liquid chromatography
100
Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates
101
Pharmacokinetics of Mirtazapine and Its Main Metabolites after Single Oral Administration in Fasting/Fed Horses
102
Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study
103
Pharmacokinetics of oral gabapentin alone or co-administered with meloxicam in ruminant beef calves
104
Pharmacokinetics of oral gabapentin in greyhound dogs
105
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy, , ,
106
Pharmacokinetics of pefloxacin mesylate in human urine using capillary electrophoresis electrochemiluminescence detection
107
Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats
108
Pharmacokinetics of piperine after oral administration of Sahastara remedy capsules in healthy volunteers
109
Pharmacokinetics of prostaglandins
110
Pharmacokinetics of protein-unbound linezolid in the blood and the mechanism of hepatobiliary excretion in the rat Original Research Article
111
Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC–tandem mass spectrometry
112
Pharmacokinetics of sodium and trihydrate amoxicillin after intravenous and intramuscular administration in llamas (Lama glama)
113
Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice
114
Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice
115
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
116
Pharmacokinetics of Sulpiride After Intravenous, Intramuscular, and Oral Single-Dose Administration in Nurse Mares
117
Pharmacokinetics of Tetracycline and Tetracycline Loaded Nanoemulsion Formula in Rabbits
118
Pharmacokinetics of tetracycline hydrochloride in fat-tailed sheep
119
Pharmacokinetics of the low molecular weight heparin dalteparin in cats
120
Pharmacokinetics of the novel atypical opioid tapentadol after intravenous, intramuscular and subcutaneous administration in cats
121
Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs
122
Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP5+, in plasma and major organs of B6C3F1 mice
123
Pharmacokinetics of the Thymidine Analog 2-Fluoro-5[14C]-methy1-1-beta-D-arabinofuranosyluracil ([14C]FMAU) in Rat Prostate Tumor Cells
124
Pharmacokinetics of tobramycin in ducks and sex-related differences
125
Pharmacokinetics of Tramadol after Epidural Administration in Horses
126
Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration
127
Pharmacokinetics of Tramadol and Its Metabolites M1, M2, and M5 in Donkeys after Intravenous and Oral Immediate Release Single-Dose Administration
128
Pharmacokinetics of tulathromycin in lactating goats
129
Pharmacokinetics of two different delivery regimens of doxorubicin in isolated hyperthermic limb perfusion
130
PHARMACOKINETICS OF UMF-078, A CANDIDATE ANTIFILARIAL DRUG, IN INFECTED DOGS
131
Pharmacokinetics of zonisamide in perinatal period
132
Pharmacokinetics Studies of some Diaryl Pyrimidinamine Derivatives as Anti-Cancer Agent: In-Silico Drug Design and Molecular Docking
133
Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine
134
Pharmacokinetics, bioavailability and tissue residues of [14C]isometamidium in non-infected and Trypanosoma congolense-infected Boran cattle
135
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel
136
Pharmacokinetics, dosage regimen and in vitro plasma protein binding of intramuscular levofloxacin in buffalo calves
137
Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl
138
Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes l-methioninase
139
Pharmacokinetics, pharmacodynamics and toxicity of a combination of metoprolol succinate and telmisartan in Wistar albino rats: Safety profiling
140
Pharmacokinetics, safety, and effects on exercise performance of l-arginine α-ketoglutarate in trained adult men
141
Pharmacokinetics, tissue distribution and excretion of a new photodynamic drug deuxemether
142
Pharmacokinetics, tissue distribution and excretion study of dictamnine, a major bioactive component from the root bark of Dictamnus dasycarpus Turcz. (Rutaceae)
143
Pharmacokinetics, urinary excretion and plasma protein binding of 2,3-butanedione monoxime in goats
144
Pharmacokinetics, urinary excretion and plasma protein binding of pralidoxime in goats
145
Pharmacokmetics and oral bioavailability of a doxycycline formulation (DOXYCYCLINE 75%) in nonfasted young pigs
146
Pharmacokmetics and oral bioavailability of a doxycycline formulation (DOXYCYCLINE 75%) in nonfasted young pigs
147
Pharmacoligical characterization of the iranian Cerastes cerastes gasperettii (Reptilia: Ophidia: Viperidae) venom
148
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
149
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
150
Pharmacologic agents for the treatment of acute bipolar mania
151
Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration Evidence of fully excitable gap in the reentrant circuit
152
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches
153
Pharmacologic and Therapeutic Differences Among Calcium Channel Antagonists: Profile of Mibefradil, a New Calcium Antagonist
154
Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
155
Pharmacologic approaches to rhythm versus rate control in atrial fibrillation—where are we now?
156
Pharmacologic approaches to therapy for vasovagal syncope
157
Pharmacologic Characterization of Wool Dust Extract in Isolated Guinea Pig Trachea
158
Pharmacologic evidence for a parasympathetic role in seizure-induced neurocardiac regulatory abnormalities
159
Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
160
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure
161
Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage
162
Pharmacologic management of childhood hypertension: current status, future challenges
163
Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician
164
Pharmacologic modulation of neutrophil functions
165
Pharmacologic modulation of the collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis
166
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: Impact on hemodynamic function and left ventricular performance
167
Pharmacologic myocardial regeneration
168
Pharmacologic Options for Aggressive Low-Density Lipoprotein Cholesterol Lowering: Benefits Versus Risks
169
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes
170
Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty
171
Pharmacologic preservation of the hemostatic system during cardiac surgery
172
Pharmacologic prevention of poterior capule opacification: in vitro effect of preervative-free lidocaine 1 % on len epithelial cell
173
Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals
174
Pharmacologic Prophylaxis and Treatment of Venous Thromboembolism after Knee Arthroplasty
175
Pharmacologic Relevance of K+Channel Remodeling in Atrial Fibrillation
176
Pharmacologic strategies for augmenting cognitive performance in schizophrenia
177
Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery
178
Pharmacologic stress echocardiography: can we forget “state-of-the-art” protocols?
179
Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis
180
Pharmacologic stress-induced regional myocardial blood flow heterogeneity and left ventricular wall thickening abnormality: Comparison of intravenous adenosine with dipyridamole in a model of critical coronary stenosis, , ,
181
Pharmacologic support with high-energy phosphate preservation in the postischemic neonatal heart
182
Pharmacologic therapies after myocardial infarction
183
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
184
Pharmacologic treatment of atherosclerosis: beyond lipid-lowering therapy
185
Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996
186
Pharmacologic treatment of schizophrenia
187
Pharmacologic Treatment of Wet Type Age-related Macular Degeneration; Current and Evolving Therapies
188
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma
189
Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation
190
Pharmacologic versus flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans
191
Pharmacologic Vitreolysis
192
Pharmacological Action of Mentha piperita on Lipid Profile in Fructose-Fed Rats
193
Pharmacological action of tick saliva upon haemostasis and the neutralization ability of sera from repeated infested hosts
194
Pharmacological Activities of Hypnea musciformis
195
Pharmacological activity of 2% aqueous acetic acid extract of Alhagi maurorum roots
196
Pharmacological algorithms for treatment resistant depression in children and adolescents
197
Pharmacological analysis of ovarial patency in Heliothis virescens
198
Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac)
199
Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats
200
Pharmacological and biological evaluation of extracts from Gratiola officinalis L. (Scrophulariaceae)
201
Pharmacological and cognitive-behavioral approaches in the treatment of childhood depression: A review and critique
202
Pharmacological and computational evaluation of Sapodilla and its constituents for therapeutic potential in hyperactive gastrointestinal disorders
203
Pharmacological and Medical Effect of Modified Skin Grafting Method in Patients with Chronic and Severe Neck Burns
204
Pharmacological and Medicinal Aspects of the Verses Containing Fig (At-tin) in Holy Quran
205
Pharmacological and Medicinal Aspects of the Verses Containing Fig (At-tin) in Holy Quran
206
Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder
207
Pharmacological and Molecular Evidence of Neuroprotective Curcumin Effects Against Biochemical and Behavioral Sequels Caused by Methamphetamine: Possible Function of CREB-BDNF Signaling Pathway
208
Pharmacological and non- pharmacological treatment of hypertension: A review article
209
Pharmacological and non-pharmacological means for prevention of fractures among elderly
210
Pharmacological and Nonpharmacological Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery
211
Pharmacological and Nonpharmacological Studies on Coronavirus Disease 2019: A Mini‑review of the Recent Evidence
212
Pharmacological and Non-pharmacological Therapeutic Strategies for Improvement of State-Trait Anxiety: A Randomized Controlled Trial Among Iranian Infertile Women With Sexual Dysfunctions
213
Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician
214
Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists Original Research Article
215
Pharmacological and Radiological Study of Patients with COVID-19 in Iran
216
Pharmacological and surgical treatments for obesity
217
Pharmacological and toxicity effects of Zhumeria majdae and its bioactive constituents: A review
218
Pharmacological and toxicity studies of the crude extracts and fractions of Hedranthera barteri leaf in rats and mice
219
Pharmacological and toxicological insights to the South African Amaryllidaceae
220
Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways
221
Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article
222
Pharmacological Approach for Prevention of Bleomycin-Induced Lung Injury
223
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
224
Pharmacological approaches to discovery and development of new mucolytic agents
225
Pharmacological Aspects of Phyllanthus fraternus Standardized Extract (Rich in Lignans and Tannins) as a Pain Modulator
226
Pharmacological blockade of gap junctions induces repetitive surging of extracellular potassium within the locust CNS
227
Pharmacological chaperones and lysosomal storage diseases
228
Pharmacological characterisation of 5-hydroxytryptamine-induced contractile effects in the isolated gut of the lepidopteran caterpillar Spodoptera frugiperda
229
Pharmacological characterisation of extraneuronal transmitter store in porcine and human coronary arteries
230
Pharmacological Characterization of A2-Adenosine Receptors in Guinea-pig Ventricular Cardiomyocytes
231
Pharmacological Characterization of Effects of UK-1745, a Novel Cardiotonic Agent withβ-Adrenoceptor-blocking Action, in Aequorin-loaded Canine Right Ventricular Muscle
232
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
233
Pharmacological characterization of micropatterned cardiac myocytes
234
Pharmacological characterization of new β-agonists using Huβ1- and Huβ2-adrenergic receptor binding assay in transfected HEK-293 cells Original Research Article
235
Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells
236
Pharmacological Concepts of Temperament in Iranian Traditional Medicine
237
Pharmacological control of bleeding during cardiac surgery
238
Pharmacological control of periodontal disease. II. Antimicrobial agents
239
Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs
240
Pharmacological Correction of Early Embryogenesis Disorders in Cows
241
Pharmacological Differences of Glitazones: Does Peroxisome Proliferator-Activated Receptor-α Activation Make the Difference?
242
Pharmacological dissociation of autonomic and behavioural responses to fear in the medullary raphe
243
Pharmacological Effect of Caffeine on Drosophila melanogaster: A Proof-of-Concept in vivo Study for Nootropic Investigation
244
Pharmacological effects of a synthetic quinoline, a hybrid of tomoxiprole and naproxen, against acute pain and inflammation in mice: a behavioral and docking study
245
Pharmacological effects of biotin
246
Pharmacological effects of gallic acid in health and diseases: A mechanistic review
247
Pharmacological effects of low- dose of aspirin on Corpus Luteum functions in mature cycling female mice
248
Pharmacological effects of low- dose of aspirin on ovulation rate in mature cycling female mice
249
Pharmacological Effects of Origanum Vulgare L. in the Elevated Plus-Maze and Open Field Test in the Rat
250
Pharmacological Effects of Peganum harmala Seeds Extract on Isolated Rat Uterus
251
Pharmacological Effects of Rosa Damascena
252
Pharmacological effects of Safranal: An updated review
253
Pharmacological effects of tiludronate in horses after long-term immobilization
254
Pharmacological Effects on Brain Morphology and Cognitive Functions in Idiopathic Generalized Epilepsy
255
Pharmacological enhancement of cutaneous flap survival with topical dimethyl sulphoxide and hydrogen peroxide
256
Pharmacological Evaluation and Synthesis ofNewSulfonamides Derivatives Based on 1,4-Benzodioxane
257
Pharmacological evaluation of [11c]donepezil as tracer for visualization of acetylcholinesterase by PET
258
Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic?
259
Pharmacological evaluation of anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (water, ethyl acetate, and n-hexane fractions): the potential medicinal plants from North Sumatra, Indonesia
260
Pharmacological evaluation of combined PGI2 agonists/thromboxane synthase inhibitors. I
261
Pharmacological Evaluation of Covid 19 Vaccine in Acute and Chronic Inflammatory Neuropathies
262
Pharmacological Evaluation of Ng5 and Ng5* Newly Synthesized Derivates of Heteroaryl-Amino-Ethanols
263
Pharmacological Evaluation of Oral Hypoglycemic and Antidiabetic Effects of Fresh Leaves Ethanol Extract of Morinda Lucida Benth. in Normal and Alloxan-Induced Diabetic Rats
264
Pharmacological Evaluation of Sedative activity of methanolic extract of Thuja occidentalis in mice.
265
Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential
266
Pharmacological Evaluation of Selected Medicinal Plants Used in the Management of Oral and Skin Infections in Ebem-Ohafia District, Abia State, Nigeria
267
Pharmacological evaluation of tea polysaccharides with antioxidant activity in gastric cancer mice
268
Pharmacological evaluation of the semi-purified fractions from the soft coral Eunicella singularis and isolation of pure compounds
269
Pharmacological evaluation of UK-14,304 analogs at cloned human α adrenergic receptors
270
Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
271
Pharmacological evidence for curcumin neuroprotective effects against lead-stimulated neurodegeneration: possible role of Akt/GSK3 signaling pathway
272
Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt- 1/GSK3 and CREB-BDNF signaling pathways
273
Pharmacological evidence for activation of phospholipid and small GTP binding protein signalling cascades by Nod factors
274
Pharmacological Evidence That Multiple Phospholipid Signaling Pathways Link Rhizobium Nodulation Factor Perception in Medicago truncatula Root Hairs to Intracellular Responses, Including Ca^2+ Spiking and Specific ENOD Gene Expression
275
Pharmacological Evidences for the Antiamnesic Effects of Desmodium gangeticum in mice
276
Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
277
Pharmacological Hypotension as a Cause of Delirious Mania ina Patient with Bipolar Disorder
278
Pharmacological implications of lengthened in-utero exposure to nevirapine Original Research Article
279
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
280
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein
281
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein
282
Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas
283
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity Original Research Article
284
Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines
285
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model
286
Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress
287
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro
288
Pharmacological intervention of traditional Chinese medicine for the quality of life in patients with colorectal cancer: a systematic review and metaanalysis
289
PHARMACOLOGICAL INTERVENTIONS FOR GERIATRIC CACHEXIA: A NARRATIVE REVIEW OF THE LITERATURE
290
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
291
PHARMACOLOGICAL INVESTIGATION OF CASSIA SOPHERA, LINN. VAR. PURPUREA, ROXB
292
Pharmacological management of interferon-induced psychiatric disorders
293
Pharmacological management of metabolic syndrome and its lipid complications
294
Pharmacological management of mild or moderate persistent asthma
295
Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches
296
Pharmacological management of tics in patients with TS
297
Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion
298
Pharmacological modulation of the hyperpolarization-activated current (If) in human atrial myocytes: focus on G protein-coupled receptors
299
Pharmacological modulation of wound healing in experimental burns
300
Pharmacological outcomes in newly diagnosed epilepsy
301
Pharmacological outcomes in older people with newly diagnosed epilepsy
302
Pharmacological outcomes in people with mental retardation and epilepsy
303
PHARMACOLOGICAL PAIN RELIEF IN PEDIATRIC PATIENTS
304
Pharmacological postconditioning with the phytoestrogen genistein
305
Pharmacological potential of ferulic acid for the treatment of metabolic syndrome and its mechanism of action: Review
306
Pharmacological Potential of Some Indonesian Medicinal Plants as Promising Options for COVID-19 During the Pandemic Era: A Literature Review
307
Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia
308
Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole
309
Pharmacological preconditioning with angiotensin converting enzyme inhibitors
310
Pharmacological preconditioning with angiotensin converting enzyme inhibitors; infarct size study
311
PHARMACOLOGICAL PRECONDITIONING WITH L-CARNITINE: RELEVANCE TO MYOCARDIAL HEMODYNAMIC FUNCTION AND GLYCOGEN AND LACTATE CONTENT
312
Pharmacological preconditioning with the adenosine triphosphate–sensitive potassium channel opener pinacidil
313
Pharmacological prevention of breast cancer: Quo Vadis?
314
Pharmacological prevention of breast cancer: Quo vadis?
315
Pharmacological prevention of prematurity
316
Pharmacological prevention of suicide in bipolar patients — A realizable target
317
Pharmacological Profile for the Contribution of NO/cGMP Pathway on Chlorpheniramine Antidepressant-Like Effect in Mice Forced Swim Test
318
Pharmacological profile of a nitric oxide donor spermine NONOate in the mouse corpus cavernosum
319
Pharmacological Profile of Oxazine and its Derivatives: A Mini Review
320
PHARMACOLOGICAL PROFILE OF SALVADORA PERSICA
321
Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals
322
Pharmacological Properties of Combination Therapies for Hypertension
323
Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats
324
Pharmacological properties of fucose. Applications in age-related modifications of connective tissues
325
Pharmacological properties of serotonin receptor subtypes mediating contraction of bovine inferior alveolar arteries
326
Pharmacological properties of some 3-substituted indole derivatives, a concise overview
327
Pharmacological properties of some 3-substituted indole derivatives, a concise overview
328
Pharmacological Properties of Vochysia Haenkeana (Vochysiaceae) Extract to Neutralize the Neuromuscular Blockade Induced by Bothropstoxin-I (Lys49 Phospholipase A2) Myotoxin
329
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
330
Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors
331
Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX
332
Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress
333
Pharmacological research in pediatrics: From neonates to adolescents
334
Pharmacological salvage of a combined distal bypass and free flap with catheter-directed thrombolysis
335
Pharmacological Screening of Annona Muricata: A Review
336
Pharmacological spinal cord protection with magnesium during replacement of the thoracic and thoracoabdominal aorta
337
Pharmacological strategies for blood loss
338
Pharmacological strategies for blood loss
339
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
340
Pharmacological stress agents for evaluation of ischemic heart disease
341
Pharmacological Studies on Khamira Marwarid: Effect on Pentylenetetrazole-Induced Seizures, Cognition and Biochemical Markers in Mice
342
Pharmacological Studies on Tetracycline and Tetracycline Nanoemulsion Formulas
343
Pharmacological study of signal transduction during stimulation of prothoracic glands from Manduca sexta
344
Pharmacological Study of the Antitumor Effect of Newcastle Oncolytic Virus in Combination with Copper Nanoparticles, Hyperthermia and Radiation on Malignant Colorectal Cancer Cell Line
345
Pharmacological therapies in fibromyalgia
346
Pharmacological therapy of osteoarthritis
347
Pharmacological therapy of Pagetʹs and other metabolic bone diseases
348
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature
349
Pharmacological treatment
350
Pharmacological treatment effects on eye movement control
351
Pharmacological Treatment in Behavioural Medicine
352
Pharmacological Treatment in Behavioural Medicine: The Importance of Neurochemistry, Molecular Biology and Mechanistic Hypotheses
353
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
354
Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004
355
Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response
356
Pharmacological treatment of chronic constipation: a literature review
357
Pharmacological treatment of established rheumatoid arthritis
358
Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain
359
Pharmacological treatment of hepatorenal syndrome: A note of optimism
360
Pharmacological treatment of multi-organ bodily distress syndrome: A double-blind, placebo-controlled trial of the effects of imipramine (stress-3)
361
Pharmacological treatment of portal hypertension: present and future
362
Pharmacological treatment of systolic heart failure
363
Pharmacological treatment of systolic heart failure
364
PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION and AWARENESS IN CORONARY ARTERY and CEREBROVASCULAR DISEASE PATIENTS
365
PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION AND AWARENESS IN CORONARY ARTERY AND CEREBROVASCULAR DISEASE PATIENTS
366
Pharmacological washout for the correct evaluation of the head-up tilt testing
367
Pharmacologically active microcarriers releasing glial cell line – derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats
368
Pharmacologically active microcarriers: a tool for cell therapy
369
Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection
370
Pharmacologically Relevant Drug Interactions of Nitrovasodilators
371
Pharmacologically relevant drug interactions of sulfonylurea antidiabetics with common herbs
372
Pharmacologically relevant drug interactions of sulfonylurea antidiabetics with common herbs
373
Pharmacologically tunable polyethylene-glycol-based cell growth substrate
374
Pharmacology – Prep Manual for Undergraduates
375
Pharmacology and clinical efficacy of angiotensin receptor blockers
376
Pharmacology and controlled release of hirudin for cardiovascular disorders
377
Pharmacology and Drug Interaction Effects of the Phosphodiesterase 5 Inhibitors: Focus on α-Blocker Interactions
378
Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
379
Pharmacology and immunology of botulinum toxin type A
380
Pharmacology and medicines management for nurses (third edition),: George Downie, Jean Mackenzie and Arthur Williams (editors)Edinburgh, Churchill Livingstone, 2003, ISBN 0443071764, Pages 600, Price £22.99
381
Pharmacology and metabolism of alcohol, including its metabolic effects and interactions with other drugs
382
Pharmacology and phytochemistry studies in Peltophorum africanum
383
Pharmacology and Therapeutics: Principles to Practice
384
Pharmacology and Toxicology of Ethinyl Estradiol and Norethindrone Acetate in Experimental Animals
385
Pharmacology and Toxicology of Leflunomide
386
Pharmacology education: a theoretical framework of applied pharmacology and therapeutics
387
Pharmacology for midwives. The evidence base for safe practice: Sue Jordan; Palgrave Macmillan, Hampshire, UK, 512pp., price £20.99 paperback, ISBN 0333693965
388
Pharmacology of antiepileptic drugs during pregnancy and lactation
389
Pharmacology of Borage (Borago officinalis L.) Medicinal Plant
390
Pharmacology of carbon nanotubes: Toxicokinetics, excretion and tissue accumulation
391
Pharmacology of carvedilol
392
Pharmacology of coronary artery bypass grafts
393
Pharmacology of drugs used in neuroanaesthesia
394
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data, ,
395
Pharmacology of Free Radicals and the Impact of Reactive Oxygen Species on the Testis
396
Pharmacology of local anaesthesia in different age groups
397
Pharmacology of modern volatile anaesthetics
398
Pharmacology of New Agents for Acute Heart Failure Syndromes
399
Pharmacology of new aromatase inhibitors
400
Pharmacology of nitrous oxide
401
Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy
402
Pharmacology of serotonin-induced salivary secretion in Periplaneta americana
403
Pharmacology of skin aging. Stimulation of glycosaminoglycan biosynthesis by L-fucose and fucose-rich polysaccharides, effect of in vitro aging of fibroblasts
404
Pharmacology of systemic analgesics
405
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells
406
Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals
407
Pharmacology of the human red cell voltage-dependent cation channel. Part II: inactivation and blocking
408
Pharmacology of the human red cell voltage-dependent cation channel: Part I. Activation by clotrimazole and analogues
409
Pharmacology of the low-molecular-weight heparins, ,
410
Pharmacology of vascular smooth muscle: C.J. Garland and J.A. Angus (Editors) Oxford University Press, Oxford, UK, 1996; stg£65.00; 435 pp.; ISBN 0-19-262387-7
411
Pharmacology Teaching Methods and Affective Factors in Their Success in Educating Undergraduate Medical Students: A Scoping Review
412
Pharmacology, taxonomy and phytochemistry of the genus Artemisia specifically from Pakistan: a comprehensive review
413
Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis
414
Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents Original Research Article
415
Pharmacophagous feeding stimulant activity of neo-clerodane diterpenoids for the turnip sawfly, Athalia rosae ruficornis
416
Pharmacophore and QSAR Modeling of Endothelial Nitric Oxide Synthase Inhibitors and Subsequent Validation and In Silico Search for New Hits
417
Pharmacophore and structure–activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase Original Research Article
418
Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
419
Pharmacophore identification and 3D-QSAR studies in N-(2-benzoyl phenyl)-l-tyrosines as PPARγ agonists Original Research Article
420
Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr5,12, Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection Original Research Article
421
Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes
422
Pharmacophore identification of KSP inhibitors
423
Pharmacophore identification of Raf-1 kinase inhibitors
424
Pharmacophore identification of α1A-adrenoceptor antagonists
425
Pharmacophore interactions analysis and prediction of inhibitory activity of 1,7-diazacarbazoles as checkpoint kinase 1 inhibitors: application of molecular docking, 3D-QSAR and RBF neural network
426
Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors
427
Pharmacophore mapping studies on indolizine derivatives as 15-LOX inhibitors
428
Pharmacophore mapping studies on pyrazoles as anti-proliferative agents
429
Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones
430
Pharmacophore modeling and atom-based 3D-QSAR studies on amino derivatives of indole as potent isoprenylcysteine carboxyl methyltransferase (Icmt) inhibitors
431
Pharmacophore modeling and in silico screening for new KDR kinase inhibitors
432
Pharmacophore modeling and molecular dynamics simulation to identify the critical chemical features against human sirtuin 2 inhibitors
433
Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors
434
Pharmacophore modeling of cytochromes P450
435
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) Original Research Article
436
Pharmacophore Modeling, Virtual Screening, Molecular Docking, DFT, and ADMET Analyses to Develop Newer generation Dual Orexin Receptor Antagonist Targeting Insomnia
437
Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as α1-adrenoceptor antagonists
438
Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors
439
Pharmacophore-based discovery of ligands for drug transporters
440
Pharmacophore-Based discovery of substituted pyridines as novel dopamine transporter inhibitors
441
Pharmacophore-Based discovery, synthesis, and biological evaluation of 4-phenyl-1-arylalkyl piperidines as dopamine transporter inhibitors
442
Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel
443
Pharmacophore-based virtual screening: The discovery of novel methionyl-tRNA synthetase inhibitors
444
Pharmacophoric features and Ca2+ ion holding capacity of verapamil
445
Pharmacophoric features of nucleosidic HIV-1RT inhibitors Original Research Article
446
Pharmacophoric features of Pseudomonas aeruginosa deacetylase LpxC inhibitors: An electronic and structural analysis
447
Pharmacophotonics: Utilizing multi-photon microscopy to quantify drug delivery and intracellular trafficking in the kidney
448
Pharmacopoeia of culture media — additional monographs (IV)
449
Pharmacopoeia of culture media—additional monographs (III)
450
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies
451
Pharmacopuncture Versus Acepromazine in Stress Responses of Horses During Road Transport
452
Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics
453
Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis
454
Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009
455
Pharmacotherapy and evolution
456
Pharmacotherapy and smoking cessation at a tobacco dependence clinic
457
Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development
458
Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review
459
Pharmacotherapy for obesity
460
Pharmacotherapy for pre diabetes: moving ahead
461
Pharmacotherapy for pregnant women with addictions
462
Pharmacotherapy for Reducing the Grieving Process of Romantic Relationship Breakup: A Clinical Trial
463
Pharmacotherapy for regional musculoskeletal pain
464
Pharmacotherapy for Retinoblastoma
465
Pharmacotherapy for severe aggression in a child with autism: “open label” evaluation of multiple medications on response frequency and intensity of behavioral intervention
466
Pharmacotherapy in acute coronary syndromes and acute myocardial infarction
467
Pharmacotherapy In Cardiopulmonary Resuscitation (CPR)
468
Pharmacotherapy in Endocrinology: Diabetes, Obesity, and Hy-perlipidemia- Review Article
469
Pharmacotherapy in percutaneous coronary intervention
470
Pharmacotherapy in the extreme longevity
471
Pharmacotherapy of bulimia nervosa and binge eating disorder
472
Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding
473
Pharmacotherapy of Depressed Children and Adolescents: Current Issues and Potential Directions
474
Pharmacotherapy of first-episode schizophrenia
475
Pharmacotherapy of impulsive aggression: A quality comparison of controlled studies
476
Pharmacotherapy of inflammatory process by ginger extract (Zingiber officinale) ointment
477
Pharmacotherapy of obesity
478
Pharmacotherapy of obesity
479
Pharmacotherapy of Prograf (Tacrolimus) in Liver Transplant Recipients; Consideration of Itsי Levels with Efficacy and Toxicity
480
Pharmacotherapy of schizophrenia
481
Pharmacotherapy of schizophrenia
482
Pharmacotherapy of schizophrenia
483
Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches
484
Pharmacotherapy of social anxiety disorder
485
Pharmacotherapy of somatoform disorders
486
Pharmacotherapy or Psychotherapy? Selective Treatment Depression in The Infertile Women with Recurrent Pregnancy Loss: A Triple-Arm Randomized Controlled Trial
487
Pharmacotherapy Plays Main Role in Managing Acute Epiploic Appendagitis: A Case Report
488
Pharmacotherapy to Improve the Acquired Aphasia following Brain Damages: A Review Study
489
Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (r-TPA) in Acute Ischemic Stroke
490
Pharmaco-toxicological study of diterpenoids Original Research Article
491
Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)
492
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
493
Pharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements
494
Pharmacovigilance in Qatar: a survey of pharmacists
495
Pharmacovigilance into 2000
496
PHARMACOVIGILANCE, 2nd Edition. R. Mann and E. Andrews, editors. Chichester:John Wiley & Sons; 2007.
497
Pharmacy and herbal medicine in the US
498
Pharmacy and Pharmacology Research in the BRICS Countries: A Scientometric Analysis
499
Pharmacy and the US Health Care System
500
Pharmacy approach to a case of acute diarrhoea with dehydration in Antalya, Turkey
501
Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions
502
Pharmacy education instruction: Preference and practices, Saudi students’ perception
503
Pharmacy impact on medication reconciliation in the medical intensive care unit
504
Pharmacy information systems in Tehran university hospitals and their relationship with pharmaceutical companies
505
Pharmacy madness
506
Pharmacy or PharmaNBIC: Thinking about 50 years ahead of pharmacy today
507
Pharmacy practice research: challenges and opportunities
508
Pharmacy practice, 3rd edition: Patricia Stone, Stephen J Curtis; Pharmaceutical Press, London, August 2002, 344pp, price £29.95 paperback, ISBN 0 85369 482 6,
509
Pharmacy Students Motivation, Preparation and Factors Affecting Pursuing Postgraduate Education in Ethiopian University
510
Pharmacy Studentsʹʹ Self-Identified Interests in a Hospital Pharmacy Internship Course in Iran
511
Pharmacy Students’ Satisfaction Rate with their Majors and its Relationship with Educational Status in Kermanshah University of Medical Sciences (2014)
512
Pharmacy Students’ Satisfaction Rate with their Majors and its Relationship with Educational Status in Kermanshah University of Medical Sciences (2014)
513
PHARMACY TOXICOLOGICAL ANALYSES FOR POISONED PATIENTS AT A TEACHING HOSPITAL IN SAUDI ARABIA
514
Pharmacyʹs attempts to extend its roles: A case study in South Africa
515
Pharmaphilia and pharmaphobia
516
p-Harmonic functions with boundary data having jump discontinuities and Baernsteinʹs problem
517
PHARMSEARCH, the Pharmaceutical Patents database produced by INPI
518
PHAROS: A pluri-detector, high-resolution, analyser of radiometric properties of soil
519
PHAROS: A pluri-detector, high-resolution, analyser of radiometric properties of soil
520
PHAROS: a spectrometer-on-a-chip for digital radiology systems with spectral detection
521
PHAROS: a spectrometer-on-a-chip for digital radiology systems with spectral detection
522
PHA–rubber blends: Synthesis, characterization and biodegradation
523
Pharyngeal Airway: An Analysis Using 2D vs. 3D Images in Different Malocclusions
524
Pharyngeal Aspiration of Complete Upper Denture in 90-Year-Old Man; a Case Report
525
Pharyngeal dysphagia in postesophagectomy patients: correlation with deglutitive biomechanics
526
Pharyngeal Myiasis Caused by Sheep Botfly, Oestrus ovis (Diptera: Oestridae) Larva, Tabriz, East Azarbaijan Province, Iran: A Case Report
527
Pharyngeal Packing during Rhinoplasty: Advantages and Disadvantages
528
Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy
529
Pharyngeal sensation and gag reflex in healthy subjects
530
Pharyngeal thyroid: a case report
531
Pharyngitis followed by hypoxia and sepsis: Lemierre syndrome
532
Pharyngitis treatment by emergency physicians from 1995 to 2001: do our antibiotic choices conform to national guidelines?
533
Pharyngocolonic Anastomosis for Esophageal Reconstruction in Corrosive Esophageal Stricture
534
Pharyngo-Colostomy With Supraglottic Partial Laryngectomy in Caustic Oropharyngeal Stricture
535
Pharyngocutaneous Fistula after Laryngectomy: Incidence, Predisposing Factors, and Outcome
536
Pharyngocutaneous Fistula as a Rare Late Postoperative Complication Following Submandibulectomy: A Case Report
537
Pharyngo-enteral anastomosis for esophageal reconstruction in diffuse corrosive esophageal stricture
538
PHARYNGOESOPHAGEAL FOREIGN BODIES
539
Pharyngoesophageal pH monitoring
540
Pharyngolaryngeal Involvement by Varicella-Zoster Virus
541
Pharyngo-oesophageal Foreign Bodies: Implications for Health Care Services in Nigeria
542
Phase (Liquid/Solid) Dependence of the Normal Spectral Emissivity for Iron, Cobalt, and Nickel at Melting Points
543
Phase 1 Trial of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Decompensated Liver Cirrhosis
544
Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
545
Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C
546
Phase accumulation model analysis of quantum well resonances formed in ultra-thin Ag, Au films on W(1 1 0)
547
Phase ac-sensitivity of oxidic and acetylacetonic gas sensors
548
PHASE ADVANCE AFTER ONE OR THREE SIMULATED DAWNS IN HUMANS
549
Phase Agility of Reflectarray Patch Element Using Nematic Liquid Crystal
550
PHASE ANALYSIS AND DENSIFICATION OF STEATITE-BASED CERAMICS
551
Phase analysis and dielectric properties of oxides obtained in the MgO–(1–x)Nb2O5–(x)Ta2O5 system
552
Phase analysis and focusing of synchrotron radiation
553
Phase analysis and focusing of synchrotron radiation
554
Phase analysis and microstructure evolution of a bone china body modified with scrap addition
555
Phase analysis and microwave dielectric properties of BaO–Nd2O3–5TiO2 composite ceramics using variable size TiO2 reagents
556
Phase analysis and microwave dielectric properties of LTCC TiO2 with glass system
557
Phase Analysis and Oxygen Storage Capacity of Ceria-Lanthana-Based TWC Promoters Prepared by Sol–Gel Routes
558
Phase analysis and wear behavior of in-situ spark plasma sintered Ti3SiC2
559
Phase analysis in delayed systems
560
Phase Analysis in the Solder Joint of Sn-Cu Solder/IMCs/Cu Substrate
561
Phase analysis of Cu(In1 − xGax)Se2 prepared by solvothermal method
562
Phase Analysis of Gated Myocardial Perfusion Single-Photon Emission Computed Tomography Compared With Tissue Doppler Imaging for the Assessment of Left Ventricular Dyssynchrony Original Research Article
563
Phase analysis of Gd5(SixGe1−x)4 alloys prepared from different purity Gd with x = 0.475 and 0.43 Original Research Article
564
Phase analysis of Gd5(SixGe1-x)4 alloys prepared from different purity Gd with x = 0.475 and 0.43
565
Phase analysis of Mg–La–Nd and Mg–La–Ce alloys
566
Phase analysis of superconducting polycrystalline MgB2
567
Phase analysis of surface layers irradiated with high-energy electron beam using Mِssbauer spectroscopy
568
Phase analysis of surface layers irradiated with high-energy electron beam using Mِssbauer spectroscopy
569
Phase analysis of TaN/Ta barrier layers in sub-micrometer trench structures for Cu interconnects
570
Phase and aggregation behaviour of alkylglycosides
571
Phase and aggregational studies of some inversely soluble aqueous formulations
572
Phase and amplitude control of optical bistability in the three-coupled quantum wells
573
Phase and amplitude of ecosystem carbon release and uptake potentials as derived from FLUXNET measurements
574
Phase and anti-phase synchronization of fractional order chaotic systems via active control
575
Phase and Correlation in `Randomʹ Seismic Fields and the Reconstruction of the Green Function
576
Phase and critical behavior in type III phase diagrams
577
Phase and electrical behaviour in the Bi14W1 − xLaxO24 − 3x/2 system
578
Phase and group synchronization in second-harmonic generation of ultrashort light pulses in one-dimensional photonic crystals
579
Phase and intensity control through diffractive optical elements in X-ray microscopy
580
Phase and microstructural evolution during the heat treatment of Sm–Ca–α-sialon ceramics
581
Phase and microstructural evolution of heat treated nanocrystalline powders in Al2O3-MgO binary system
582
Phase and microstructural evolution of Ir–Si binary alloys with fcc/silicide structure
583
Phase and microstructural evolution of yttrium-doped nanocrystalline alumina: A contribution of advanced microscopy techniques
584
Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings
585
Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings
586
Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings
587
Phase and microstructure evolution during hydrothermal solidification of clay–quartz mixture with marble dust source of reactive lime
588
Phase and microstructure evolution during the synthesis of WC nanopowders via thermal processing of the precursor
589
Phase and microstructure evolution in precursor plasma-sprayed YIG coatings
590
Phase and microstructure formation and their influence on the strength of two types of glass-ceramics
591
Phase and microstructure of TbCu7-type SmFe melt-spun powders
592
Phase and microstructure of tungsten coating on C/C composite prepared by double-glow plasma
593
Phase and microstructure stabilities of LiAlO2 in molten Li/Na carbonate for molten carbonate fuel cells
594
Phase and morphological transformations of GaS single crystal surface by thermal treatment
595
Phase and morphology changes induced by acid treatment following alkaline reaction of mesoporous anatase: Effect of anions
596
Phase and morphology control of LTA/FAU zeolites by adding trace amounts of inorganic ions
597
Phase and morphology dependence on the annealing temperature of tin sulfides and oxides prepared by thermal decomposition of organotin precursors
598
Phase and morphology evolution of bismuth ferrites via hydrothermal reaction route
599
Phase and morphology evolution study of ball milled Mg–Co hydrogen storage alloys
600
Phase and morphology investigation of BaxSr1−xTiO3 (x = 0.6, 0.7 and 0.8) powders
601
Phase and morphology investigation of BaxSr1−xTiO3 (x = 0.6, 0.7 and 0.8) powders
602
Phase and orientational ordering of A–B–A tri-block co-polymers guest in a quenched host of low molecular weight rod molecules
603
Phase and reaction equilibria of acetic acid–1-pentanol–water– n-amyl acetate system at 760 mm Hg
604
Phase and reaction equilibria of the acetic acid-isopropanol-isopropyl acetate-water system at 760 mmHg
605
Phase and rheological behaviors of xanthan/amylose and xanthan/starch mixed systems
606
Phase and scaling properties of determinants arising in topological field theories
607
Phase and sedimentation behavior of oil (octane) dispersions in the presence of model mineral aggregates
608
Phase and shape controlling of MnS nanocrystals in the solvothermal process
609
Phase- and shape-controlled hydrothermal synthesis of CdS nanoparticles, and oriented attachment growth of its hierarchical architectures
610
Phase- and shape-controlled synthesis of cadmium hydroxyl chloride microstructures via an ammonia-assisted conversion of 1D CdQCl (Q=quinoline) complex microwires Original Research Article
611
Phase and size control of nanometer-size materials synthesized in supersonic jet expansions
612
Phase and size control of nanometer-size materials synthesized in supersonic jet expansions
613
Phase and size separations occurring during the injection of model pastes composed of β-tricalcium phosphate powder, glass beads and aqueous solutions
614
Phase and space resolved optical emission spectroscopic investigations of an inductively coupled RF plasma using an imaging acousto-optic spectrometer
615
Phase and spectral properties of optically injected semiconductor lasers
616
Phase and state transition effects on dielectric, mechanical, and thermal properties of polyols
617
Phase and structural behavior of SmAlO3–RAlO3 (R = Eu, Gd) systems
618
Phase and structural change of carbonized wood materials by hydrothermal treatment
619
Phase and structural changes of Nd12Fe82B6 alloy during mechanical milling in both an argon and a hydrogen atmosphere
620
Phase and structural characterization of Sr2Nb2O7 and SrNbO3 thin films grown via pulsed laser ablation in O2 or N2 atmospheres
621
Phase and Structural Modifications in Porous Silicon Under Pulse Heating
622
Phase and structural transformations in magnetorheological suspensions
623
Phase and structure transformations in the titanium interlayer during the nickel silicidation on Si(1 0 0) substrate
624
Phase and Surface Properties of Lipid Bilayers Containing Neoglycolipids
625
Phase and texture analysis of a hydride blister in a Zr–2.5%Nb tube by synchrotron X-ray diffraction Original Research Article
626
Phase and thermal stability of nanocrystalline hydroxyapatite prepared via microwave heating
627
Phase and valence transitions in Ba2LnSnxNb1−xO6−δ
628
Phase and valence transitions in Ba2LnSnxSb1−xO6−δ (Ln=Pr and Tb)
629
Phase and velocity distributions in vertically upward high-viscosity two-phase flow
630
Phase and viscosity behaviour of refrigerant–lubricant mixtures
631
Phase and volumetric behavior of binary systems containing carbon dioxide and lubricants for transcritical refrigeration cycles
632
Phase and volumetric behaviour of mixtures of carbon dioxide (R-744) and synthetic lubricant oils
633
Phase angle dependence of sand density observable in hyperspectral reflectance
634
Phase angle in the Cu/polyimide/alumina system
635
Phase angle in the Cu/polyimide/alumina system
636
Phase Angle Measurement in Healthy Human Subjects through Bio-Impedance Analysis
637
Phase angle spectrum analysis and body water
638
Phase approximation by logarithmic sampling of gain
639
Phase assemblages of (Ca,Mg)-α-sialon ceramics derived from an α-sialon powder prepared by SHS
640
Phase assembly and microstructure of CeO2-doped ZrO2 ceramics prepared by spark plasma sintering
641
Phase association of polycyclic aromatic hydrocarbons in the Minjiang River Estuary, China
642
Phase associations and lipid distributions in the seasonally ice-covered Arctic estuary of the Mackenzie Shelf
643
Phase associations and potential selective extraction methods for selected high-tech metals from ferromanganese nodules and crusts with siderophores
644
Phase associations of barium in marine sediments
645
Phase Asymptotic Semiflows, Poincaréʹs Condition, and the Existence of Stable Limit Cycles
646
Phase asynchrony between coronal index and sunspot numbers Original Research Article
647
Phase attraction in sensorimotor synchronization with auditory sequences: Effects of Tsingle and periodic distractors on synchronization accuracy.
648
Phase averaging of the coherent head-on beam–beam instability
649
Phase averaging of the coherent head-on beam–beam instability
650
Phase averaging of the precessing vortex core in a swirl burner under piloted and premixed combustion conditions
651
Phase balancing using mixed-integer programming [distribution feeders]
652
Phase balancing using simulated annealing
653
Phase barograms–phase diagrams of vapor pressure: Eutectoid phase formation in binary systems
654
Phase based feature detector consistent with human visual system characteristics
655
Phase behavior
656
Phase behavior and a modified Kwei equation for ternary polymer blends containing stereoregular PMMA
657
Phase behavior and characterization of ionic liquids based microemulsions
658
Phase behavior and compressibility factor of two China gas condensate samples at pressures up to 95 MPa
659
Phase behavior and crystal structure of 3-(1-naphthyloxy)- and 3-(4-indolyloxy)-propane-1,2-diol, synthetic precursors of chiral drugs propranolol and pindolol
660
Phase Behavior and Crystal Structure of Perovskite-Type Rare Earth Complex Oxides
661
Phase behavior and crystallization in blends of a low molecular weight polyethylene-block-poly(ethylene oxide) diblock copolymer and poly(hydroxyether of bisphenol A)
662
Phase behavior and emulsion formation of novel fluoroether amphiphiles in carbon dioxide
663
Phase behavior and extraction characteristics of polycyclic aromatic hydrocarbon mixtures with hexane in sub- and supercritical state
664
Phase behavior and hydrogen bonding in biomembrane mimicing polyurethanes with long side chain fluorinated alkyl phosphatidylcholine polar head groups attached to hard block
665
Phase behavior and interfacial curvature in water-oil-surfactant systems
666
Phase behavior and its viscoelastic response of polylactide/poly(ε-caprolactone) blend
667
Phase behavior and kinetics of a new bond-order potential for silicon
668
Phase behavior and Lα-phase of a new catanionic system formed by cationic hydrocarbon and anionic fluorocarbon surfactants
669
Phase behavior and mechanism of membrane formation for polyimide/DMSO/water system
670
Phase behavior and mesoscale solubilization in aqueous solutions of hydrotropes
671
Phase behavior and microstructural length scales of a diblock copolymer in the presence of a selective solvent
672
Phase behavior and microstructure of preheated soy proteins and κ-carrageenan mixtures
673
Phase behavior and microstructures of the Gemini (12-3-12,2Br−)–SDS–H2O ternary
674
Phase behavior and miscibility in blends of poly(sebacic anhydride)/poly(ethylene glycol)
675
Phase behavior and mixed ionic–electronic conductivity of Ba4Sb2O9
676
Phase behavior and modeling of the poly(methyl methacrylate)–CO2–methyl methacrylate system
677
Phase behavior and modeling of the systems CO2-acetonitrile and CO2-acrylic acid
678
Phase behavior and molecular chain environment of organic–inorganic hybrid materials based on poly(n-butyl methacrylate-co-(3-(methacryloxypropyl)) trimethoxysilane)
679
Phase behavior and morphology of poly(phenylene ether)/epoxy blends
680
Phase behavior and optical- and mechanical properties of the binary system isotactic polypropylene and the nucleating/clarifying agent 1,2,3-trideoxy-4,6:5,7-bis-O-[(4-propylphenyl) methylene]-nonitol
681
Phase behavior and optical investigation of two synthetic luminol derivatives and glycolipid mixed monolayers at the air–water interface
682
Phase behavior and phase structure of 1:1 salt-free catanionic surfactant dodecyltrimethylammonium decanoate
683
Phase behavior and physical properties of petroleum reservoir fluids from acoustic measurements
684
Phase behavior and process parameters effects on the characteristics of precipitated theophylline using carbon dioxide as antisolvent
685
PHASE BEHAVIOR AND PROPERTIES OF POLYURETHANE-PVC BLENDS AND FIBERS
686
PHASE BEHAVIOR AND PROPERTIES OF POLYURETHANE-PVC BLENDS AND FIBERS
687
Phase behavior and protein partitioning in aqueous two-phase systems of cationic–anionic surfactant mixtures
688
Phase behavior and reaction of polyethylene in supercritical water at pressures up to 2.6 GPa and temperatures up to 670°C
689
Phase behavior and rheology in water and in model paint formulations thickened with HM-EHEC: influence of the chemical structure and the distribution of hydrophobic tails
690
Phase behavior and SANS investigations of edible sugar–limonene microemulsions
691
Phase behavior and size variation of AOT-based W/O microemulsions by substituting H+ for Na+ as the counterion
692
Phase behavior and size variation of Na-AOT-based W/O microemulsions by increasing NaOH concentration in the water pool
693
Phase behavior and spherical hollow particle formation by dipeptide-based two-headed amphiphiles in a mixed solvent of dimethyl sulfoxide and water
694
Phase behavior and structure formation for diblock copolymers composed of side-chain liquid crystalline and glassy amorphous components
695
Phase behavior and surface tensions of amphiphilic fluorinated random copolymer aqueous solutions
696
Phase behavior and thermodynamic properties in the system Fe–Al
697
Phase behavior and thermodynamic properties in the system Fe–Al
698
Phase behavior and vapor pressures of the pyrene + 9,10-dibromoanthracene system
699
Phase behavior and viscous properties of cetyltrimethylammonium bromide and sodium dodecyl sulfonate aqueous mixtures
700
Phase behavior and water vapor transport in BIONOLLE/polymethylmethacrylate blends
701
Phase behavior applications of SAFT based equations of state—from associating fluids to polydisperse, polar copolymers
702
Phase behavior at low temperature of poly(tetrafluoroethylene) by temperature-modulated calorimetry
703
Phase behavior for carbon dioxide + ethanol system: Experimental measurements and modeling with a cubic equation of state
704
Phase behavior for carbon dioxide/tetraalkoxysilane systems
705
Phase behavior for the [Bmim]BF4 aqueous two-phase systems containing ammonium sulfate/sodium carbonate salts at different temperatures: Experimental and correlation
706
Phase behavior for the poly(dimethylsiloxane) in supercritical fluid solvents
707
Phase behavior for the poly[2-(2-ethoxyethoxy)ethyl acrylate] and 2-(2-ethoxyethoxy)ethyl acrylate in supercritical solvents
708
Phase behavior for the supercritical ethylene + hexane + polyethylene systems
709
Phase behavior in liquid crystallization for diblock copolymers consisting of rubbery amorphous and side-chain liquid crystalline components
710
Phase behavior in mixtures of cationic surfactant and anionic polyelectrolytes
711
Phase behavior in the system LaxSr1-xMnO(5+x)/2 (x=0.8-1.0) with trivalent state of manganese ion
712
Phase behavior measurement for poly(isobornyl acrylate) + cosolvent systems in supercritical solvents at high pressure
713
Phase behavior measurement for the system CO2 + glycerol + ethanol at high pressures
714
Phase behavior measurement of the binary carbon dioxide–N,N-dimethylacetamide and carbon dioxide–N,N-diethylacetamide systems at high pressure
715
Phase behavior measurement on the binary mixture for isopropyl acrylate and isopropyl methacrylate in supercritical CO2
716
Phase behavior of (polyacrylamides + water) solutions: concentration, pressure and isotope effects
717
Phase behavior of 1,3,5-tri-tert-butylbenzene–carbon dioxide binary system
718
Phase behavior of a model surfactant–solvent system at intermediate and high densities
719
Phase behavior of a near-critical reservoir fluid mixture
720
Phase behavior of a nematic liquid crystal in polybutadiene networks
721
Phase behavior of a simple model of ferrocolloidal fluid
722
Phase behavior of a ternary system of poly[p-perfluorooctyl-ethylene(oxy, thio, sulfonyl)methyl styrene] and poly[p-decyl(oxy, thio, sulfonyl)methyl styrene] in supercritical solvents
723
Phase behavior of a two-dimensional quenched–annealed lattice gas with nearest-neighbor attraction. Grand canonical Monte Carlo simulation
724
Phase behavior of amphiphile–solvent systems from lattice Monte Carlo simulations
725
Phase behavior of an amphiphilic molecule in the presence of two solvents by dissipative particle dynamics
726
Phase behavior of aqueous two-phase systems composed of 1-alkyl-3-methylimidazolium bromide + Rb2CO3/Cs2CO3 + water
727
Phase behavior of aqueous two-phase systems composed of 1-ethyl-3-methylimidazolium tetrafluoroborate and phosphate-based salts at different temperatures
728
Phase behavior of Athabasca bitumen + water mixtures at high temperature and pressure
729
Phase behavior of banana-shaped molecules under pressure
730
Phase Behavior of Binary and Ternary Mixtures of Poly(decyl acrylate)-Supercritical Solvents-Decyl Acrylate and Poly(decyl methacrylate)-CO2-Decyl Methacrylate Systems
731
Phase behavior of binary mixture for the isoalkyl acetate in supercritical carbon dioxide
732
Phase behavior of binary mixture of asphaltene + solvent and ternary mixture of asphaltene + solvent + precipitant
733
Phase behavior of binary mixtures of thick and thin hard rods
734
Phase Behavior of Binary Stockmayer and Polarizable Lennard-Jones Fluid Mixtures Using Adiabatic Nuclear and Electronic Sampling
735
Phase behavior of biodegradable amphiphilic poly(l,l-lactide)-b-poly(ethylene glycol)-b-poly(l,l-lactide)
736
Phase behavior of blends of high temperature copolycarbonates with styrene/acrylonitrile copolymers
737
Phase behavior of blends of linear and branched polyethylenes on micron length scales via ultra-small angle neutron scattering (USANS)
738
Phase behavior of blends of linear low density polyethylene and poly(ethene-propene-1-butene)
739
Phase behavior of blends of poly(2,6-dimethyl-1,4-phenylene oxide)/polystyrene/poly(o-chlorostyrene-co-p-chlorostyrene) copolymer
740
PHASE BEHAVIOR OF BROMINATED POLY(ISOBUTYLENE-co-4-METHYLSTYRENE)/ GENERAL PURPOSE RUBBER BLENDS
741
PHASE BEHAVIOR OF BROMINATED POLY(ISOBUTYLENE-co-4-METHYLSTYRENE)/ GENERAL PURPOSE RUBBER BLENDS
742
Phase behavior of carbon dioxide mixtures with n-alkanes and n-perfluoroalkanes
743
Phase behavior of carbon dioxide + medroxyprogesterone acetate system at high pressures
744
Phase behavior of carbon dioxide—low-molecular weight triglycerides binary systems: measurements and thermodynamic modeling
745
Phase behavior of castor oil in compressed propane and n-butane
746
Phase behavior of catalytic deactivated compounds and water with 1-ethyl-3-methylimidazolium acetate [EMIM][OAc] ionic liquid at T = 298.15–323.15 K and p = 1 bar
747
Phase behavior of CO2 + polyethylene glycol + ethanol at pressures up to 20 MPa
748
Phase behavior of concentrated hydroxypropyl methylcellulose solution in the presence of mono and divalent salt
749
Phase behavior of crosslinked polyisoprene rubber and supercritical carbon dioxide
750
Phase behavior of didecylpyrrolidium bromide in aqueous solution
751
Phase behavior of diisobutyl adipate–carbon dioxide mixtures
752
Phase behavior of dipalmitoylphosphatidylethanolamine in dimethylsulfoxide–water mixture
753
Phase behavior of DNA in the presence of cetyltrimethylammonium bromide \ alkyl polyglucoside surfactant mixture
754
Phase behavior of DNA solutions in the presence of salts
755
Phase behavior of imidazolium and phosphonium tetrafluoroborates with dihydroxy alcohols
756
Phase Behavior of Ionic Liquid-LiX Mixtures: Pyrrolidinium Cations and TFSI- Anions
757
Phase behavior of iridescent phases with calcium dodecyl sulfate, octanol or decanol, and water, and the effect of the presence of sodium ions
758
Phase behavior of isotactic polypropylene/C4-solvents at high pressure. Experimental data and SAFT modeling
759
Phase behavior of lemon and bergamot peel oils in supercritical CO2
760
Phase behavior of Lennard-Jones fluids in pores formed between two cylindrical walls
761
Phase behavior of LiClO4-doped poly(ε-caprolactone)-b-poly(ethylene oxide) hybrids in the presence of competitive interactions
762
Phase behavior of linear polystyrene-block-poly(2-vinylpyridine)-block-poly(tert-butyl methacrylate) triblock terpolymers
763
Phase behavior of liquid-crystalline copolymer/liquid crystal blends
764
Phase behavior of magnetic nanoparticles dispersions in bulk and confined geometries
765
Phase behavior of metals at very high P–T conditions: A review of recent experimental studies Original Research Article
766
Phase behavior of methane and carbon dioxide hydrates in meso- and macro-sized porous media
767
Phase behavior of microemulsions based on food-grade nonionic surfactants: effect of polyols and short-chain alcohols
768
Phase behavior of mixtures of ionic liquids and organic solvents
769
Phase behavior of n-hexadecyl phosphate in Gibbs adsorption layers
770
Phase behavior of ovalbumin and carboxymethylcellulose composite system
771
Phase behavior of phytosterols and cholesterol in carbon dioxide-expanded ethanol
772
Phase behavior of poly(1,1-dihydroperfluorooctylacrylate) in supercritical carbon dioxide
773
Phase behavior of poly(3-alkylthiophene)/polystyrene blends
774
Phase behavior of poly(dimethylsiloxane)–poly(ethylene oxide) amphiphilic block and graft copolymers in compressed carbon dioxide
775
Phase behavior of poly(ether imide) in mixtures of N-methyl-2-pyrrolidinone and methylene chloride
776
Phase behavior of poly(N-isopropylacrylamide) in binary aqueous solutions
777
Phase behavior of poly(N-isopropylacrylamide) in water–methanol cononsolvent mixtures and its relevance to membrane formation
778
Phase behavior of polyaniline/dodecyl benzene sulphonic acid mixture
779
Phase behavior of polyetherimide/benzophenone/triethylene glycol ternary system and its application for the preparation of microporous membranes
780
Phase behavior of polymer/diluent/diluent mixtures and their application to control microporous membrane structure
781
Phase behavior of polymer–diluent systems characterized by temperature modulated differential scanning calorimetry
782
Phase behavior of polymers containing ether groups in carbon dioxide
783
Phase behavior of polymer–solvent mixtures
784
Phase behavior of polypropylene + n-pentane and polypropylene + n-pentane + carbon dioxide: modeling with cubic and non-cubic equations of state
785
Phase behavior of propane and n-pentane aerosol particles under conditions relevant to Titan
786
Phase behavior of random and ABC triblock methacrylic polyampholytes with poly(vinyl alcohol) in water: effect of pH and salt
787
Phase behavior of reservoir fluids: Comparisons of PC-SAFT and cubic EOS simulations
788
Phase Behavior of Rigid Objects on a Cubic Lattice
789
Phase behavior of Safaniya vacuum residue
790
Phase behavior of selected artificial lipids
791
Phase behavior of semicrystalline polymer blends
792
Phase behavior of serpentine mineral by carbothermal reduction nitridation
793
Phase Behavior of Sick House Syndrome(SHS) Chemicals
794
Phase behavior of siloxane-based amphiphiles in supercritical carbon dioxide
795
Phase behavior of some mono-substituted ferrocene- and [3]ferrocenophane-containing nematics with the cyclohexane ring in the rigid core
796
Phase behavior of sour natural gas systems using classical and statistical thermodynamic equations of states
797
Phase behavior of soybean oil, castor oil and their fatty acid ethyl esters in carbon dioxide at high pressures
798
Phase behavior of sunflower oil and soybean oil in propane and sulphur hexafluoride
799
Phase behavior of supercritical CO2/Styrene/Poly(ethylene terephthlate) (PET) system and preparation of polystyrene/PET composites
800
Phase behavior of ternary mannosylerythritol lipid/water/oil systems
801
Phase Behavior of the Binary and Ternary Mixtures of Biodegradable Poly((epsilon)-caprolactone) in Supercritical Fluids
802
Phase behavior of the binary refrigerant mixture chlorodifluoro-ethane (R22)-1,1,1,2-tetrafluoro-ethane (R134a): experimental investigation and theoretical modelling using the perturbed-anisotropic-chain theory (PACT)
803
Phase behavior of the binary system ethane+linalool
804
Phase behavior of the binary system near-critical dimethylether and tripalmitin: measurements and thermodynamic modeling
805
Phase behavior of the monoolein–water system: The effects of addition of the hydrocarbon 1,8-cineole and supercritical carbon dioxide
806
Phase behavior of the orange essential oil/sodium bis(2-ethylhexyl)sulfosuccinate/water system
807
Phase behavior of the poly(neopentyl methacrylate) + supercritical fluid solvents + neopentyl methacrylate system and CO2 + neopentyl methacrylate mixtures at high pressure
808
Phase behavior of the poly(vinyl pyrrolidone) + N-vinyl-2-pyrrolidone + carbon dioxide system
809
Phase behavior of the poly(vinyl pyrrolidone) + dichloromethane + supercritical carbon dioxide system
810
Phase behavior of the system hyperbranched polyglycerol + methanol + carbon dioxide
811
Phase behavior of the system lecithin–water: The effects of addition of the hydrocarbon 1,8-cineole and supercritical carbon dioxide
812
Phase behavior of the ternary 1-hexyl-3-methylimidazolium tetrafluoroborate + carbon dioxide + methanol system
813
Phase behavior of the ternary aqueous mixtures of two polydisperse ethoxylated nonionic surfactants
814
Phase behavior of the vanillin–CO2 system at high pressures
815
Phase behavior of tri-block copolymers in solution: Mesoscopic simulation study
816
Phase behavior of tricyanomethanide-based ionic liquids with alcohols and hydrocarbons
817
Phase behavior of two-component membranes
818
Phase behavior of unsymmetrical dimers on a square lattice
819
Phase behavior of vinyl fluoride in room-temperature ionic liquids [emim][Tf2N], [bmim][N(CN)2], [bmpy][BF4], [bmim][HFPS] and [omim][TFES]
820
Phase behavior of water + hydrocarbon binary systems by using multi-fluid nonrandom lattice hydrogen bonding theory
821
Phase behavior of water-in-supercritical carbon dioxide microemulsion with sodium salt of bis(2,2,3,3,4,4,5,5-octafluoro-1-pentanol) sulfosuccinate
822
Phase behavior of xenon hydrate system
823
Phase behavior of β-d galactose pentaacetate–carbon dioxide binary system
824
Phase behavior on the poly[octyl (meth)acrylate] + supercritical fluid solvents + monomer and CO2 + monomer mixtures at high pressure
825
Phase behavior prediction of complex petroleum fluids
826
Phase behavior prediction of petroleum fluids with minimum characterization data
827
Phase behavior studies of a perfluoropolyether in high-pressure carbon dioxide
828
Phase behavior studies of a perfluoropolyether in high-pressure carbon dioxide
829
Phase behavior study of amphiphilic drugs: Effect of pharmaceutical excipients
830
Phase behavior study of paclitaxel loaded amphiphilic copolymer in two solvents by dissipative particle dynamics simulations
831
Phase behavior study of PEB/PES blend by time resolved laser light scattering
832
Phase behavior, formation, and rheology of cubic and hexagonal phase based gel emulsions in water/tetraglyceryl lauryl ether/oil systems
833
Phase behavior, microstructure transition, and antiradical activity of sucrose laurate/propylene glycol/the essential oil of Melaleuca alternifolia/water microemulsions
834
Phase behavior, morphology and interfacial structure in thermoset/thermoplastic elastomer blends of poly(propylene glycol)-type epoxy resin and polystyrene–b-polybutadiene
835
Phase behavior, nucleation and optical properties of the binary system isotactic polypropylene/N,N′,N″-tris-isopentyl-1,3,5-benzene-tricarboxamide
836
Phase behavior, ordering and self-assembly in monolayers
837
Phase behavior, photopolymerization, and morphology development in mixtures of eutectic nematic liquid crystal and photocurable monomer
838
Phase behavior, polymorphism and spherulite morphology in Poly(1,4-butylene adipate) interacting with two structurally similar acrylic polymers
839
Phase Behavior, Thermal Stability and Rheological Properties of PPEK/PC Blends
840
Phase behaviors and light scattering for dilute mixtures of C12E5 and lauric acid
841
Phase behaviors for the supercritical ethylene + 1-hexene + hexane + polyethylene systems at elevated temperatures and pressures
842
Phase behaviors of ammonia/R-125 mixtures
843
Phase behaviors of bidisperse nanoparticle/block copolymer mixtures in dilute solutions
844
Phase Behaviors of Binary Hard-Sphere Mixtures Using Simple Analytical Equations of State
845
Phase behaviors of comb-like liquid crystalline polysiloxanes containing fluorinated mesogenic units
846
Phase behaviors of Gemini cationic surfactants/n-butanol/water systems
847
Phase behaviors of polymer solution confined between two concentric cylinders
848
Phase behaviors of smectic-A liquid crystal/linear polymer systems Original Research Article
849
Phase behaviors of solid polymer electrolyte/salt systems in lithium secondary battery: the ionic interaction and nonrandomness effect
850
Phase behaviors of solid polymer electrolytes/salt system in lithium secondary battery by group-contribution method: The pressure effect
851
Phase behaviors of sphere-forming triblock copolymers confined in nanopores: A dynamic density functional theory study
852
Phase behaviour and density of (methane+n-butane)
853
Phase behaviour and density of model reservoir fluids at high temperature and pressure
854
Phase behaviour and in vitro hydrolysis of wheat starch in mixture with whey protein
855
Phase behaviour and miscibility window in UCST-type blends of poly(styrene-co-acrylonitrile) and tetramethylbisphenol A oligosulfones
856
Phase behaviour and non-periodic crystallisation of random aromatic copolyesters and their side chain bearing systems
857
Phase behaviour and physico-chemical properties of the binary systems {1-ethyl-3-methylimidazolium thiocyanate, or 1-ethyl-3-methylimidazolium tosylate + water, or + an alcohol}
858
Phase behaviour and thermodynamics of poly(1,4-phenylene ether sulphone) and poly(ethylene oxide)/alkali-metal salt complex blends: a thermal analysis study
859
Phase behaviour in the vicinity of the three-phase solid–liquid–vapour line in asymmetric nonpolar systems at high pressures
860
Phase behaviour of 1-butyl-1-methylpyrrolidinium thiocyanate ionic liquid
861
Phase behaviour of 1-hexyloxymethyl-3-methyl-imidazolium and 1,3-dihexyloxymethyl-imidazolium based ionic liquids with alcohols, water, ketones and hydrocarbons: The effect of cation and anion on solubility
862
Phase behaviour of 1-methyl-3-octylimidazolium bis[trifluoromethylsulfonyl]imide with thiophene and aliphatic hydrocarbons: The influence of n-alkane chain length
863
Phase behaviour of a liquid crystalline polyetherester derived from 4′-hydroxy-1,1′-biphenyl-4-carboxylic acid and the ether-diol 4-(3-hydroxypropoxy)butan-1-ol
864
Phase behaviour of a mixed ionic/nonionic surfactant system used to prepare stable oil-in-water paraffin emulsions
865
Phase behaviour of a non-ionic surfactant–polymeric solution–water system during the phase inversion process
866
Phase behaviour of binary fluid mixtures: a global phase diagram solely in terms of pure component properties
867
Phase behaviour of binary mixtures of colloidal charged spheres
868
Phase behaviour of binary mixtures of LC compounds of different molecular structure and comparable molecular length: I. 4-(4′-Substituted phenylazo)phenyl-4″-alkoxybenzoates and 4-(4′-substituted phenyl carbonyloxy)phenyl-4″-alkoxybenzoates
869
Phase behaviour of dipalmitoylphosphatidylcholine/surfactant/water systems studied by infrared spectroscopy
870
Phase behaviour of gas hydrates of carbon dioxide in the presence of tetrahydropyran, cyclobutanone, cyclohexane and methylcyclohexane
871
Phase behaviour of gelatin/polydextrose mixtures at high levels of solids
872
Phase behaviour of globular protein and flexible polymer in an aqueous medium
873
Phase behaviour of heteronuclear dimers adsorbed on square and triangular lattices—a Monte Carlo study
874
Phase behaviour of high molecular mass methyl esters in supercritical ethane
875
Phase behaviour of high molecular weight oat β-glucan/whey protein isolate binary mixtures
876
Phase behaviour of hyperbranched polyesters and polyethers with modified terminal OH groups in supercritical solvents
877
Phase behaviour of ionic liquid 1-butyl-1-methylpyrrolidinium tris(pentafluoroethyl)trifluorophosphate with alcohols, water and aromatic hydrocarbons
878
Phase behaviour of lipid–cholesterol membranes
879
Phase behaviour of l-lactic acid based polymers of low molecular weight in supercritical carbon dioxide at high pressures
880
Phase behaviour of l-lactide in supercritical carbon dioxide at high pressures
881
Phase behaviour of Maya crude oil based on calorimetry and rheometry
882
Phase behaviour of microemulsions stabilised by double chain cationic surfactants and alcohol co-surfactants
883
Phase behaviour of mixtures containing antibiotics: Effect of hydrogen bonding on tetracycline partitioning
884
Phase behaviour of oat β-glucan/sodium caseinate mixtures varying in molecular weight
885
Phase behaviour of oxygen adsorbed on graphite
886
Phase Behaviour of Palm Oil Fatty Acid Components in Supercritical Carbon Dioxide
887
Phase behaviour of polymer emulsions during the phase inversion process in the presence of non-ionic surfactants
888
Phase behaviour of pure micellar casein/κ-carrageenan systems in milk salt ultrafiltrate
889
Phase behaviour of RbH2AsO4 above room temperature
890
Phase behaviour of SMMA and SAN blends using Floryʹs equation of state theory
891
Phase behaviour of ternary system styrene–maleic anhydride (SMA) and two styrene–acrylonitrile (SAN) copolymers having different compositions
892
Phase behaviour of the binary mixtures of substituted analogues of LC compounds of the type 4-(4′-substituted phenylazo)-1-naphthyl-4″-alkoxybenzoates
893
Phase behaviour of the binary system ethane+limonene
894
Phase behaviour of the catalyst dicarbonyl(η5-cyclopentadienyl)-cobalt in carbon dioxide
895
Phase behaviour of water+nonionic surfactant systems: experiments and modelling applying the Peng–Robinson equation of state with the Wong–Sandler mixing rules and the UNIQUAC gE-model
896
Phase behaviour study of chalcone in dense CO2
897
Phase behaviour, rheological properties, and microstructure of oat β-glucan-milk mixtures
898
Phase behaviour, rheology and microstructure of mixture of meat proteins and kappa and iota carrageenans
899
Phase bifurcations of electron gas at the conditions of diamagnetic instability
900
Phase Boundaries and Crystallization of Polyethylene in n-Pentane and n-Pentane + Carbon Dioxide Fluid Mixtures
901
Phase boundaries as agents of structural change in macromolecules
902
Phase boundaries of the φ-Al10Cu10Fe1 phase
903
Phase boundary between ilmenite and perovskite structures in MnGeO3 determined by in situ X-ray diffraction measurements
904
Phase Boundary Estimation in Two-Phase Flows with Electrical Impedance Imaging Technique
905
Phase boundary migration, Kirkendall marker shift and atomic mobilities in fcc Au–Pt alloys
906
Phase boundary of dilute lattice spin glasses
907
Phase boundary of pressure-induced I4mm to Cmc21 transition in ammonia borane at elevated temperature determined using Raman spectroscopy
908
Phase boundary of the Zr-rich region in commercial grade Zr–Nb alloys
909
Phase boundary solutions to model kinetic equations via the Conley index theory. Part I
910
Phase boundary solutions to model kinetic equations via the Conley index theory. Part II
911
Phase breaks and chaos in a chain of diffusively coupled oscillators
912
Phase Calibration Technique for Mismatch Optimization in Image-Reject Receivers
913
PHASE CENTRE OPTIMIZATION IN PROFILED CORRUGATED CIRCULAR HORNS WITH PARALLEL GENETIC ALGORITHMS
914
Phase change and electrical resistivity of Zn–Mn–Ni–O-based NTC thermistors produced using IZC powder recycled from used dry batteries
915
Phase change and heat transfer characteristics of a eutectic mixture of palmitic and stearic acids as PCM in a latent heat storage system
916
Phase change and optical band gap behavior of Se0.8S0.2 chalcogenide glass films
917
Phase change behaviour of some latent heat storage media based on calcium chloride hexahydrate
918
Phase change characteristic study of spherical PCMs in solar energy storage
919
Phase change composite based on porous nickel and erythritol
920
Phase change cool storage using dimethyl-sulfoxide
921
Phase change detection of attractive force gradient by using a quartz resonator in noncontact atomic force microscopy
922
Phase change dynamics in a polymer thin film upon femtosecond and picosecond laser irradiation
923
Phase change flattening process for axial grooved heat pipe
924
Phase change heat transfer and bubble behavior observed on twisted wire heater geometries in microgravity
925
Phase change heat transfer device for process heat applications Original Research Article
926
Phase change in calcination process for BaTi2O5 and proposal of a new temperature profile
927
Phase change in porous media
928
Phase change material (PCM) storage for free cooling of buildings—A review
929
Phase change material applications in buildings: An environmental assessment for some Spanish climate severities Original Research Article
930
Phase change material cellulosic composites for the cold storage of perishable products: From material preparation to computational evaluation
931
Phase change material for enhancing solar water heater, an experimental approach
932
Phase change material: Optimizing the thermal properties and thermal conductivity of myristic acid/palmitic acid eutectic mixture with acid-based surfactants
933
Phase change material-based building architecture for thermal management in residential and commercial establishments
934
Phase Change Materials (PCM) microcapsules with different shell compositions: Preparation, characterization and thermal stability
935
Phase change materials based on high-density polyethylene filled with microencapsulated paraffin wax
936
Phase change materials based on low-density polyethylene/paraffin wax blends
937
Phase change materials for limiting temperature rise in building integrated photovoltaics
938
Phase change materials for smart textiles – An overview
939
Phase change materials for thermal energy storage
940
Phase change materials formed by uv curable epoxy matrix and Fischer–Tropsch paraffin wax
941
Phase change materials in the ternary system NH4Cl+CaCl2+H2O
942
Phase change of a plane wave propagating through polymer dispersed liquid crystal film with nanosized droplets
943
Phase change of a two-component liquid–liquid dispersion
944
Phase change of bimetallic PdCo electrocatalysts caused by different heat-treatment temperatures: Effect on oxygen reduction reaction activity
945
Phase change of formation water and the formation of deep basin gas: A case from the Upper Paleozoic, Ordos Basin
946
Phase Change of Lennard-Jones Nano Clusters Containing Non Magic Numbers
947
Phase change of polycyclic aromatic hydrocarbon clusters by mass addition
948
Phase change optical recording films based on Bi2Te3–Sb2Te3 alloys
949
Phase change performance of sodium acetate trihydrate with AlN nanoparticles and CMC
950
Phase change phenomena during high power laser-materials interaction
951
Phase change phenomena during high power laser-materials interaction
952
Phase change phenomena in silicon microchannels
953
Phase change problems with temperature dependent constraints for the volume fraction velocities Original Research Article
954
Phase change process with free convection in a circular enclosure: numerical simulations
955
Phase change processes in microdroplets: OTSC-investigation of saturated solutions
956
Phase change writing in a GeSbTe film with scanning near-field optical microscope
957
Phase change writing in a GeSbTe film with scanning near-field optical microscope
958
Phase changes during silica particle formation in water-in-oil emulsions
959
Phase changes in : A synchrotron X-ray powder diffraction study
960
Phase changes in boron ignition and combustion
961
Phase changes in lithium amide–borohydride complexes under high pressure
962
Phase changes in metal combustion
963
Phase changes of benzo(a)pyrene in supercritical water combustion
964
Phase changes of ceramic whiteware slip-casting bodies studied by XRD and FTIR
965
Phase changes of solid methane under high pressure up to 86 GPa at room temperature
966
Phase changes of the AISI 430 ferritic stainless steels after high-temperature gas nitriding and tempering heat treatment
967
Phase characteristics of a number of U–Pu–Am–Np–Zr metallic alloys for use as fast reactor fuels
968
Phase characteristics of a U–20Pu–3Am–2Np–15Zr metallic alloy containing rare earths Original Research Article
969
Phase characterization and electrical conductivity of LaSr(GaMg)1−xMnxO3 system
970
Phase characterization in three monofilament BSCCO 2223/Ag tapes
971
Phase characterization of debris generated in brake pad coefficient of friction tests
972
Phase chemistry and thermochemistry on coordination behavior of zinc acetate with methionine
973
Phase chemistry of the superalloy SC16 after creep deformation Original Research Article
974
Phase classification, electrical conductivity, and thermal stability of Bi2(V0.95TM0.05)O5.5 + δ (TM: transition metal)
975
Phase coexistence between the (√3 × √3)R30° – β and (1 × 1) phases on Pb/Ge(1 1 1)
976
Phase coexistence in a single DNA molecule
977
Phase coexistence in annealed CaMn7O12
978
Phase coexistence in confined Ising systems: a density matrix renormalization approach
979
Phase coexistence in image solid solutions
980
Phase coexistence in polydisperse mixture of hard-sphere colloidal and flexible chain particles
981
Phase coexistence in the hard-sphere Yukawa chain fluid with chain length polydispersity: High temperature approximation
982
Phase coexistence induced by a defensive reaction in a cellular automaton traffic flow model
983
Phase coexistence region and dielectric properties of PZT ceramics
984
Phase coherence in chaotic oscillatory media
985
Phase Coherence in Quantum Brownian Motion
986
Phase coherence in the cotunneling regime of a coupled double quantum dot
987
Phase coherent transmission through interacting mesoscopic systems
988
Phase coherent transmission through interacting mesoscopic systems
989
Phase coherent transport in two coupled quantum dots
990
Phase compactons
991
Phase Compensation of Ideal Inductances Based Second-Generation Current Conveyors
992
Phase components of the sintered Mg–x wt% LaNi5 (x=20–50) composites and their hydrogenation properties Original Research Article
993
Phase composition and catalytic properties in methanol decomposition of iron–ruthenium modified activated carbon Original Research Article
994
Phase composition and elemental partitioning in glass–ceramics containing high-Na/Al high level waste
995
Phase composition and heat of crystallisation of amorphous calcium phosphate in ultra-fine radio frequency suspension plasma sprayed hydroxyapatite powders Original Research Article
996
Phase composition and in vitro bioactivity of porous implants made of bioactive glass S53P4
997
Phase composition and interface of starch–gelatin blends studied by synchrotron FTIR micro-spectroscopy
998
Phase composition and in-vitro bioactivity of plasma sprayed calcia stabilized zirconia coatings
999
Phase composition and its changes during annealing of plasma-sprayed YSZ
1000
Phase composition and magnetic properties of niobium–iron codoped TiO2 nanoparticles synthesized in Ar/O2 radio-frequency thermal plasma
